Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study

We studied the effects of treatment with olmesartan/amlodipine and olmesartan/hydrochlorothiazide on inflammatory and metabolic parameters (including new-onset diabetes as a secondary endpoint) in non-diabetic hypertensive patients with metabolic syndrome (MetS). A total of 120 patients with MetS an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Martinez-Martin, F J, Rodriguez-Rosas, H, Peiro-Martinez, I, Soriano-Perera, P, Pedrianes-Martin, P, Comi-Diaz, C
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3099035/
https://ncbi.nlm.nih.gov/pubmed/21107432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jhh.2010.104
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados